Trial
NCT01279681
Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
National Cancer Institute (NCI); Cancer and Leukemia Group B
Condition
Cognitive/Functional Effects
Intervention
bevacizumab
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-12-08